INCOMPANYOFOTHERS.COM: Keyword Density Checker

Total words: 2276 | 2-word phrases: 593 | 3-word phrases: 662 | 4-word phrases: 685

PAGE INFO

Title	Try to keep the title under 60 characters (56 characters) RYANODEX® (dantrolene sodium) \| RYANODEX® for MH
Description	Try to keep the meta description between 50 - 160 characters (21 characters) Page Description Here
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (47 characters) Designed for fast and efficient administration1

#	Keyword	Frequency	Density
1	of malignant hyperthermia	5	0.76%
2	of dantrolene sodium	4	0.60%
3	malignant hyperthermia in	4	0.60%
4	sterile water for	4	0.60%
5	treatment of malignant	4	0.60%
6	the treatment of	4	0.60%
7	water for injection	3	0.45%
8	ryanodex® dantrolene sodium	3	0.45%
9	supportive measures and	2	0.30%
10	in patients at	2	0.30%
11	hyperthermia in patients	2	0.30%
12	prevention of malignant	2	0.30%
13	malignant hyperthermia mh	2	0.30%
14	in the treatment	2	0.30%
15	conjunction with appropriate	2	0.30%
16	appropriate supportive measures	2	0.30%
17	with appropriate supportive	2	0.30%
18	patients at high	2	0.30%
19	dantrolene sodium for	2	0.30%
20	at high risk	2	0.30%
21	important safety information	2	0.30%
22	of ryanodex® contains	2	0.30%
23	vial of ryanodex®	2	0.30%
24	is indicated for	2	0.30%
25	for the treatment	2	0.30%
26	indicated for the	2	0.30%
27	less sterile water	2	0.30%
28	malignant hyperthermia malignant	2	0.30%
29	that can help	2	0.30%
30	response that can	2	0.30%

#	Keyword	Frequency	Density
1	the treatment of malignant	4	0.58%
2	sterile water for injection	3	0.44%
3	of malignant hyperthermia in	3	0.44%
4	treatment of malignant hyperthermia	3	0.44%
5	rapid response that can	2	0.29%
6	fewer vials and less	2	0.29%
7	ryanodex® dantrolene sodium for	2	0.29%
8	in patients at high	2	0.29%
9	hyperthermia in patients at	2	0.29%
10	less than 1 minute1	2	0.29%
11	in less than 1	2	0.29%
12	vial of ryanodex® contains	2	0.29%
13	prevention of malignant hyperthermia	2	0.29%
14	response that can help	2	0.29%
15	malignant hyperthermia in patients	2	0.29%
16	less sterile water for	2	0.29%
17	with appropriate supportive measures	2	0.29%
18	patients at high risk	2	0.29%
19	indicated for the treatment	2	0.29%
20	is indicated for the	2	0.29%
21	conjunction with appropriate supportive	2	0.29%
22	for the treatment of	2	0.29%
23	appropriate supportive measures and	2	0.29%
24	in the treatment of	2	0.29%
25	of malignant hyperthermia mh	2	0.29%
26	only drug approved to	1	0.15%
27	antagonist—the only drug approved	1	0.15%
28	1 antagonist—the only drug	1	0.15%
29	is a ryanodine receptor	1	0.15%
30	ryanodex® is a ryanodine	1	0.15%
31	moa ryanodex® is a	1	0.15%
32	action moa ryanodex® is	1	0.15%
33	of action moa ryanodex®	1	0.15%
34	supportive measures and for	1	0.15%
35	mechanism of action moa	1	0.15%
36	ryanodex® mechanism of action	1	0.15%
37	measures and for the	1	0.15%
38	patients at high risk7	1	0.15%
39	the prevention of malignant	1	0.15%
40	drug approved to specifically	1	0.15%

#	URL	Whois	Check
1	http://www.eagleus.com/privacy-policy	Whois	eagleus.com
2	http://www.eagleus.com/terms-of-use	Whois	eagleus.com
3	https://www.eagleus.com/contact/	Whois	eagleus.com
4	http://www.eagleus.com/	Whois	eagleus.com
5	https://www.eagleus.com/privacy-policy/	Whois	eagleus.com
6	https://www.eagleus.com/privacy-policy/#cookiepolicy	Whois	eagleus.com
7	https://www.eagleus.com/privacy-policy/#californiaresidents	Whois	eagleus.com